WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.
Historical research on reduction of childhood mortality due to vaccination To what extent has the National Vaccination Programme contributed to the prevention of disease and mortality since the beginning of the 20th century?
Need for adjustment authorisation for gene drive applications The National Institute for Public Health and the Environment (RIVM) advises to bring all gene drive applications under the authorisation requirement of the Dutch GMO legislation.
New film on Zoonoses RIVM aims to improve the collaboration between the human and veterinary health sectors. This makes it possible to intervene quickly and efficiently in case of a zoonotic disease outbreak.
Increasing number of girls immunised against HPV In 2014 the number of girls who were immunised against the human papilloma virus (HPV) rose. This virus can cause cervical cancer later in life.
Aquatic organisms inadequately protected against insecticide imidacloprid RIVM proposes that the water quality standard for the insecticide imidacloprid be reduced by a factor of eight.
RIVM investigates dangers of e-cigarette At the request of State Secretary Martin van Rijn (VWS), RIVM is carrying out an investigation into the safety of e-cigarettes.
Annual GLOBE day: A closer look at RIVM soil Today, April 8th, RIVM welcomes education professionals for the annual GLOBE day.